Page 35 - Read Online

8. de Ory F, Guisasola ME, Sanz JC, García‑Bermejo I. Evaluation 20. Zivadinov R, Zorzon M, Weinstock‑Guttman B, Serafin M, Bosco A,
of four commercial systems for the diagnosis of Epstein‑Barr virus Bratina A, Maggiore C, Grop A, Tommasi MA, Srinivasaraghavan B,
primary infections. Clin Vaccine Immunol 2011;18:444‑8. Ramanathan M. Epstein‑Barr virus is associated with grey matter
9. Polman CH, Reingold SC, Banwell B, Clanet M, Cohen JA, Filippi M, atrophy in multiple sclerosis. J Neurol Neurosurg Psychiatry
Fujihara K, Havrdova E, Hutchinson M, Kappos L, Lublin FD, 2009;80:620‑5.
Montalban X, O’Connor P, Sandberg‑Wollheim M, Thompson AJ, 21. Brettschneider J, Tumani H, Kiechle U, Muche R, Richards G,
Waubant E, Weinshenker B, Wolinsky JS. Diagnostic criteria for Lehmensiek V, Ludolph AC, Otto M. IgG antibodies against measles,
multiple sclerosis: 2010 revisions to the McDonald criteria. Ann rubella, and varicella zoster virus predict conversion to multiple
Neurol 2011;69:292‑302. sclerosis in clinically isolated syndrome. PLoS One 2009;4:e7638.
10. Robertson P, Beynon S, Whybin R, Brennan C, Vollmer‑Conna U, 22. Lindsey JW, Hatfield LM, Vu T. Epstein‑Barr virus neutralizing
Hickie I, Lloyd A. Measurement of EBV‑IgG anti‑VCA avidity aids and early antigen antibodies in multiple sclerosis. Eur J Neurol
the early and reliable diagnosis of primary EBV infection. J Med 2010;17:1263‑9.
Virol 2003;70:617‑23. 23. Gray JJ. Avidity of EBV VCA‑specific IgG antibodies: distinction
11. Gärtner BC, Hess RD, Bandt D, Kruse A, Rethwilm A, between recent primary infection, past infection and reactivation.
Roemer K, Mueller‑Lantzsch N. Evaluation of four commercially J Virol Methods 1995;52:95‑104.
available Epstein‑Barr virus enzyme immunoassays with an 24. Lünemann JD, Jelcic I, Roberts S, Lutterotti A, Tackenberg B,
immunofluorescence assay as the reference method. Clin Diagn Lab Martin R, Münz C. EBNA1‑specific T cells from patients with multiple
Immunol 2003;10:78‑82. sclerosis cross react with myelin antigens and co‑produce IFN‑gamma
12. James JA, Harley JB, Scofield RH. Epstein‑Barr virus and systemic and IL‑2. J Exp Med 2008;205:1763‑73.
lupus erythematosus. Curr Opin Rheumatol 2006;18:462‑7. 25. Jilek S, Kuhle J, Meylan P, Reichhart MD, Pantaleo G, Du
13. Villegas E, Santiago O, Carrillo JA, Sorlózano A, Guerrero M, Pasquier RA. Severe post‑EBV encephalopathy associated with
Fernández O, Gutiérrez J. Low intrathecal immune response of myelin oligodendrocyte glycoprotein‑specific immune response.
anti‑EBNA‑1 antibodies and EBV DNA from multiple sclerosis J Neuroimmunol 2007;192:192‑7.
patients. Diagn Microbiol Infect Dis 2011;70:85‑90. 26. Jilek S, Schluep M, Meylan P, Vingerhoets F, Guignard L, Monney A,
14. Castellazzi M, Tamborino C, Cani A, Negri E, Baldi E, Seraceni S, Kleeberg J, Le Goff G, Pantaleo G, Du Pasquier RA. Strong
+
Tola MR, Granieri E, Contini C, Fainardi E. Epstein‑Barr virus‑specific EBV‑specific CD8 T‑cell response in patients with early multiple
antibody response in cerebrospinal fluid and serum of patients with sclerosis. Brain 2008;131:1712‑21.
multiple sclerosis. Mult Scler 2010;16:883‑7. 27. Kiriyama T, Kataoka H, Kasai T, Nonomura A, Ueno S. Negative
15. Pohl D, Rostasy K, Jacobi C, Lange P, Nau R, Krone B, Hanefeld F. association of Epstein‑Barr virus or herpes simplex virus‑1 with
Intrathecal antibody production against Epstein‑Barr and other tumefactive central nervous system inflammatory demyelinating
neurotropic viruses in pediatric and adult onset multiple sclerosis. disease. J Neurovirol 2010;16:466‑71.
J Neurol 2010;257:212‑6.
16. Sargsyan SA, Shearer AJ, Ritchie AM, Burgoon MP, Anderson S,
Hemmer B, Stadelmann C, Gattenlöhner S, Owens GP, Gilden D, Cite this article as: Zhang SC, Liu L, Wang RJ, Tuo HZ, Guo YJ, Yi L,
Bennett JL. Absence of Epstein‑Barr virus in the brain and CSF of Wang DX, Wang JW. Detection of Epstein-Barr virus infection subtype
patients with multiple sclerosis. Neurology 2010;74:1127‑35. in patients with multiple sclerosis by indirect immunofluorescence assay.
17. Jafari N, van Nierop GP, Verjans GM, Osterhaus AD, Middeldorp JM, Neuroimmunol Neuroinflammation 2014;1(1):24-8.
Hintzen RQ. No evidence for intrathecal IgG synthesis to Epstein Barr Source of Support: The work was supported by Beijing Natural Science
virus nuclear antigen‑1 in multiple sclerosis. J Clin Virol 2010;49:26‑31. Foundation (Nos. 7102040, 7132060), National Natural Science Foundation
18. Jaquiéry E, Jilek S, Schluep M, Meylan P, Lysandropoulos A, of China (Nos. 81041020, 81271311 and 81241039), Traditional Chinese
Pantaleo G, Du Pasquier RA. Intrathecal immune responses to EBV Medicine, Beijing Technology Development Fund (No. SF-2007-III-22),
in early MS. Eur J Immunol 2010;40:878‑87. Beijing Excellent Talent Foundation (No. 20071-D0300100062), the
19. Cepok S, Zhou D, Srivastava R, Nessler S, Stei S, Büssow K, high-level technical training project funding of the Beijing health system
Sommer N, Hemmer B. Identification of Epstein‑Barr virus proteins (2011-3-004) and the preferential funding scheme for Beijing city staff to go
abroad. Conflict of Interest: No.
as putative targets of the immune response in multiple sclerosis.
J Clin Invest 2005;115:1352‑60. Received: 04-05-2014; Accepted: 29-05-2014

28 Neuroimmunol Neuroinflammation | Volume 1 | Issue 1 | June 2014